Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bile Acid Pool Change on Metformin PD and Microbiome
NCT04335526Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Maximum blood glucose concentration at Day 9 and Gut microbiome species change at Day 9. Started May 2020; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04335526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335526.